5 Asbestos Victims Receive $190 Million in NYC’s Largest Compensation Payout By Companies
Asbestos Victims Were All Tradespeople Working for Burnham Corporation, Cleaver-Brooks Companies
By Kristen Griffin
Tag: Mesothelioma News
Tories sold asbestos victims cheaply
The government’s response to the terms of the mesothelioma Bill was disgraceful yet not surprising.
Tories sold asbestos victims cheaply
The government’s response to the terms of the mesothelioma Bill was disgraceful yet not surprising.Source: www.topix.com Via newsmixx: home News
Injury and Disability Lawyers Release New Informational Graphic about …
The law firm of d’Oliveira & Associates has issued a new infographic on mesothelioma.
Injury and Disability Lawyers Release New Informational Graphic about …
The law firm of d’Oliveira & Associates has issued a new infographic on mesothelioma.Source: www.topix.com Via newsmixx: home News
Workers Win $190M in Asbestos Case
A New York jury has ordered two companies to hand over $190 million to five workers, including a painter and construction worker, who contracted mesothelioma after being exposed to asbestos on the job.
Workers Win $190M in Asbestos Case
A New York jury has ordered two companies to hand over $190 million to five workers, including a painter and construction worker, who contracted mesothelioma after being exposed to asbestos on the job.Source: www.topix.com Via newsmixx: home News
Tragic Quebec Derailment Forces Wichita to Revisit Emergency Action Plan
Wichita Area Residents Would Be At Serious Health Risk if Derailment Released Asbestos, Hazardous Chemicals
By Kristen Griffin
Potential new target to treat malignant pleural mesothelioma
Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis.
Researchers find potential new target to treat malignant pleural mesothelioma
Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options.
Potential new target to treat malignant pleural mesothelioma
Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis.Source: www.topix.com Via newsmixx: home News
Researchers find potential new target to treat malignant pleural mesothelioma
Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options.Source: www.topix.com Via newsmixx: home News
Potential new target to treat malignant pleural mesothelioma
Researchers conclude that Ephrin B2 seems to play an important role in malignant pleural mesothelioma cell lines and tumors.
Potential new target to treat malignant pleural mesothelioma
Researchers conclude that Ephrin B2 seems to play an important role in malignant pleural mesothelioma cell lines and tumors.
Potential new target to treat malignant pleural mesothelioma
Researchers conclude that Ephrin B2 seems to play an important role in malignant pleural mesothelioma cell lines and tumors.Source: feeds.sciencedaily.com Via newsmixx: home News